Please login to the form below

Alfred Sandrock

This page shows the latest Alfred Sandrock news and features for those working in and with pharma, biotech and healthcare.

of our findings,” said Alfred Sandrock head of research and development at Biogen.

Biogen and Ionis post ‘encouraging’ early results for Alzheimer’s disease candidate

Biogen is encouraged by the results of this trial, and we look forward to our continued research in future clinical studies with this promising investigational asset,” said Alfred Sandrock, head of
Biogen pays InnoCare $125m upfront for potential multiple sclerosis treatment

programs,” said Alfred Sandrock, Jr., head of research and development at Biogen.
FDA narrows label for Biogen’s Aduhelm to only include mild forms of Alzheimer’s disease

We are committed to continue to listen to the community’s needs as clinical practice adapts to this important, first-in-class treatment option,” said Alfred Sandrock, head of research and
Biogen discontinues clinical development of anti-tau antibody for Alzheimer’s disease

from each trial,” said Alfred Sandrock, head of research and development at Biogen.
Biogen, Sage’s depression therapeutic zuranolone hits primary endpoint in phase 3

Together with our collaboration partners at Sage, we are proud to announce highly encouraging results from the phase 3 WATERFALL Study of zuranolone in major depressive disorder,” said Alfred Sandrock, Jr.,

More from news
Approximately 1 fully matching, plus 15 partially matching documents found.

Biogen's Douglas Williams departs for biotech start-up

Williams will be replaced by chief medical officer Alfred Sandrock and chief scientific officer Spyros Artavanis-Tsakonas, who will be handed joint responsibility for Biogen Research and Development. ... We are fortunate to have Al Sandrock and Spyros
Biogen Idec names VP for value-based medicine

Through his years of hands-on clinical experience, he has gained a truly unique understanding of the needs of MS patients,” said Alfred Sandrock, chief medical officer of Biogen Idec.

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Scientific Director, MRNA/ Covid 19, Medical Communications, UK: Six figure salary

Client Services Director, MRNA/ Covid 19, Medical Communications...: Highly competitive salary

Principal Medical Writer, MRNA/ Covid 19, Medical Communications...: Highly competitive salary

Vaccines writer – career opportunity to move into medcomms from ...: Highly competitive salary

Senior Account Exec > CSD – Medical Communications – UK, Lond...: Highly Competitive Salary, Bonus &Benefits

Medical Writers > Scientific Directors – Medical Communicatio...: Highly Competitive Salary, Bonus &Benefits

PR/ PA Account Executive (UK Healthcare Industry specialist, cam...: Competitive

Account Supervisor – Leading Healthcare Advertising Agency – New...: Highly Competitive Salary, Bonus &Benefits

HR Manager – Recruitment/ Generalist combined role, Marketing ag...: circa £50K

Senior Medical Writer – Creative Healthcare Advertising – New Yo...: Highly Competitive Salary, Bonus &Benefits

Add my company

OUR GOAL: To help clients Metamorph™ Science into Action that changes healthcare to improve the lives of patients. Empowering Strategic...

What does the future hold for Light-chain Amyloidosis?: Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Webinar:: Securing a future for telehealth with immersive market research insights...
Accelerating patient recruitment in clinical trials with the Clinical Enrolment Managers (CEMs): How Innovative Trials' global Clinical Enrolment Managers (CEMs) give clinical trial sites the local touch...

Email:
Password: